Summary

The global hemostats market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.73% during 2024-2032. The rising surgical procedures, technological advancements, expansion of healthcare infrastructure, increasing awareness among healthcare professionals, and a growing aging population are some of the major factors propelling the market.

Hemostats are medical instruments used to control bleeding by clamping blood vessels or tissue during surgical procedures or wound treatment. They typically consist of a pair of hinged, scissor like handles with serrated jaws at the working end. When the handles are squeezed, the jaws close, creating a firm grip on the tissue or blood vessel. This prevents the flow of blood and facilitates precise manipulation or suturing. Hemostats come in various sizes and designs, making them versatile tools in healthcare settings. They play a crucial role in ensuring a bloodless surgical field, reducing the risk of excessive bleeding, and enabling effective medical procedures.

The rising incidence of surgical procedures, including complex surgeries, minimally invasive procedures, and trauma cases, represents the prime factor fueling the demand for hemostatic agents and instruments. Moreover, as the global population continues to age, the prevalence of chronic diseases necessitating surgical interventions, such as cardiovascular diseases and cancer, is increasing, aiding in market expansion. Concurrent with this, ongoing advancements in medical technology have led to the development of innovative hemostatic products with improved efficacy and safety profiles, further propelling market growth. Additionally, the growing awareness among healthcare professionals about the importance of effective hemostasis to reduce complications and enhance patient outcomes has driven the adoption of hemostats. Furthermore, the expansion of healthcare infrastructure in emerging markets, coupled with increasing healthcare expenditure, is contributing to the growth of the hemostats market as access to surgical care becomes more widespread.

Hemostats Market Trends/Drivers:
Increasing surgical procedures

The growing number of surgical procedures worldwide is a significant driver for the hemostats market. Surgical interventions are essential for treating various medical conditions, from routine procedures like appendectomies to complex surgeries like organ transplants. As the global population continues to grow and age, the prevalence of chronic diseases such as cardiovascular diseases, cancer, and orthopedic issues is also on the rise. This has led to an increasing demand for surgical interventions, and consequently, hemostatic agents and instruments. Hemostats are crucial in these procedures to control bleeding, reduce the risk of complications, and improve patient outcomes.

Ongoing technological advancements

Advances in medical technology have played a pivotal role in the growth of the hemostats market. These innovations have led to the development of more effective and safer hemostatic products. For example, newer hemostats often incorporate biocompatible and bioabsorbable materials, reducing the risk of adverse reactions. Additionally, some hemostatic agents are engineered to work more rapidly, thus saving valuable surgical time. Moreover, advancements in surgical techniques, such as minimally invasive surgery, have increased the demand for specialized hemostatic tools tailored to these procedures. Technological innovations continue to drive product development, enhancing the overall market.

Healthcare infrastructure expansion in emerging markets

Emerging markets, particularly in Asia, Latin America, and Africa, are experiencing significant growth in healthcare infrastructure and expenditure. This expansion is driven by urbanization, rising disposable incomes, and increased government initiatives to improve healthcare access. As healthcare facilities become more accessible, the number of surgical procedures performed in these regions is on the rise. Consequently, there is a growing demand for hemostatic agents and instruments to support these surgeries. The expansion of healthcare infrastructure not only increases the market's geographical reach but also fosters opportunities for partnerships and collaborations between local and international hemostat manufacturers.

Hemostats Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global hemostats market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and formulation.

Breakup by Product:

Thrombin Based
Combination Based
Oxidized Regenerated Cellulose Based
Gelatin Based
Collagen Based

Thrombin based dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes thrombin based, combination based, oxidized regenerated cellulose based, gelatin based, and collagen based. According to the report, thrombin based represented the largest segment.

The demand for thrombin based hemostats is being propelled by their rapid action and versatility in managing bleeding in various medical scenarios. Thrombin is a naturally occurring enzyme that plays a crucial role in the blood clotting process. Thrombin-based hemostats offer a targeted and rapid solution for achieving hemostasis, making them particularly valuable in situations where time is critical, such as emergency surgeries and trauma cases. Furthermore, their ability to work independently of the body's clotting mechanisms makes them an attractive option, and their compatibility with other hemostatic agents enhances their versatility in surgical applications, further driving their demand in the healthcare industry.

Breakup by Application:

Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Others

General surgery holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes orthopedic, general, neurological, cardiovascular, reconstructive, gynecological, and other surgeries. According to the report, general surgery accounted for the largest market share.

The increasing complexity and diversity of surgical procedures represent one of the main factors impelling the need for hemostats in general surgery applications. General surgery encompasses a wide range of operations, from abdominal surgeries to vascular procedures, each posing unique challenges in achieving effective hemostasis. Surgeons are increasingly relying on hemostatic agents and instruments to minimize bleeding, reduce operating time, and enhance patient outcomes. As surgical techniques advance, minimally invasive procedures become more common, necessitating specialized hemostatic tools. Moreover, the expanding aging population with comorbidities requires more surgical interventions, further fueling the demand for reliable and versatile hemostats in general surgery applications.

Breakup by Formulation:

Matrix and Gel Hemostats
Sheet and Pad Hemostats
Sponge Hemostats
Powder Hemostats

Matrix and gel hemostats dominate the market

The report has provided a detailed breakup and analysis of the market based on the formulation. This includes matrix and gel, sheet and pad, sponge, and powder hemostats. According to the report, matrix and gel hemostats represented the largest segment.

The demand for matrix and gel hemostats is driven by their unique characteristics, such as ease of application and versatility in various medical settings. These hemostatic products offer a user-friendly approach to achieving hemostasis, especially in situations where precise control is essential, such as neurosurgery and ophthalmic procedures. Matrix and gel hemostats conform to irregular wound shapes and adhere well to tissues, ensuring effective sealing of bleeding sites. Apart from this, they often have a resorbable nature, reducing the risk of adverse reactions and minimizing the need for postoperative removal, making them increasingly favored by surgeons and healthcare professionals in diverse clinical applications.

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America exhibits a clear dominance, accounting for the largest hemostats market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North American hemostats market is experiencing significant growth due to the region's aging population driving a higher prevalence of chronic diseases, resulting in an increased demand for surgical interventions, which in turn necessitates the use of hemostatic agents and instruments. Concurrent with this, the well-established healthcare infrastructure in North America, coupled with high healthcare expenditure, allows for extensive adoption of advanced hemostatic technologies and products. Additionally, ongoing technological advancements in the healthcare sector, particularly in the United States, are contributing to the development of innovative hemostatic solutions that are highly sought after by healthcare providers. Furthermore, the region's regulatory environment and stringent quality standards ensure the availability of safe and effective hemostats, further boosting market growth. Apart from this, the rising awareness among healthcare professionals regarding the importance of efficient hemostasis to minimize complications is propelling the North America hemostats market forward.

Competitive Landscape:
The global hemostats market is characterized by intense competition, driven by a multitude of established and emerging players striving to gain a competitive edge. Key market participants include leading healthcare companies that have a strong global presence and offer a wide range of hemostatic products. These industry giants engage in extensive research and development efforts to introduce innovative hemostats and expand their product portfolios. Additionally, smaller, niche-focused companies are gaining prominence by offering specialized hemostatic solutions. Collaborations, partnerships, and mergers and acquisitions are common strategies in this dynamic landscape, aimed at strengthening market positions and enhancing product offerings. The competitive rivalry is further fueled by the increasing demand for minimally invasive surgery and the ongoing quest to develop hemostatic agents with enhanced safety profiles, driving continuous innovation and competitiveness in the global hemostats market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Arch Therapeutics Inc.
Baxter International Inc.
B. Braun Melsungen Aktiengesell
C. R. Bard Inc.
GELITA MEDICAL GmbH
Integra LifeSciences Corporation
Johnson & Johnson
Pfizer Inc.
Stryker Corporation
Teleflex Incorporated
Z-Medica LLC

Recent Developments:
In July 2023, Baxter International Inc. announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable hemostatic powder that is ready to use and designed for patients with intact coagulation to address mild bleeding.
In April 2023, Arch Therapeutics, Inc. a marketer and developer of novel self-assembling wound care and biosurgical products, unveiled its AC5® Advanced Wound System (“AC5”) at the Symposium on Advanced Wound Care. .

Key Questions Answered in This Report:
How has the global hemostats market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global hemostats market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the formulation?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global hemostats market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hemostats Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Thrombin Based
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Combination Based
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Oxidized Regenerated Cellulose Based
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Gelatin Based
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Collagen Based
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Application
7.1 Orthopedic Surgery
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 General Surgery
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Neurological Surgery
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cardiovascular Surgery
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Reconstructive Surgery
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Gynecological Surgery
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Formulation
8.1 Matrix and Gel Hemostats
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Sheet and Pad Hemostats
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Sponge Hemostats
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Powder Hemostats
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Arch Therapeutics Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Baxter International Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 B. Braun Melsungen Aktiengesell
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 C. R. Bard Inc. (BD)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 GELITA MEDICAL GmbH
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Integra LifeSciences Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Johnson & Johnson
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Stryker Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Teleflex Incorporated
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Z-Medica LLC
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
List of Figures
Figure 1: Global: Hemostats Market: Major Drivers and Challenges
Figure 2: Global: Hemostats Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Hemostats Market: Breakup by Product (in %), 2023
Figure 4: Global: Hemostats Market: Breakup by Application (in %), 2023
Figure 5: Global: Hemostats Market: Breakup by Formulation (in %), 2023
Figure 6: Global: Hemostats Market: Breakup by Region (in %), 2023
Figure 7: Global: Hemostats Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 8: Global: Hemostats Market (Thrombin Based): Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Hemostats Market Forecast (Thrombin Based): Sales Value (in Million US$), 2024-2032
Figure 10: Global: Hemostats Market (Combination Based): Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Hemostats Market Forecast (Combination Based): Sales Value (in Million US$), 2024-2032
Figure 12: Global: Hemostats Market (Oxidized Regenerated Cellulose Based): Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Hemostats Market Forecast (Oxidized Regenerated Cellulose Based): Sales Value (in Million US$), 2024-2032
Figure 14: Global: Hemostats Market (Gelatin Based): Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Hemostats Market Forecast (Gelatin Based): Sales Value (in Million US$), 2024-2032
Figure 16: Global: Hemostats Market (Collagen Based): Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Hemostats Market Forecast (Collagen Based): Sales Value (in Million US$), 2024-2032
Figure 18: Global: Hemostats Market (Orthopedic Surgery): Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Hemostats Market Forecast (Orthopedic Surgery): Sales Value (in Million US$), 2024-2032
Figure 20: Global: Hemostats Market (General Surgery): Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Hemostats Market Forecast (General Surgery): Sales Value (in Million US$), 2024-2032
Figure 22: Global: Hemostats Market (Neurological Surgery): Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Hemostats Market Forecast (Neurological Surgery): Sales Value (in Million US$), 2024-2032
Figure 24: Global: Hemostats Market (Cardiovascular Surgery): Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Hemostats Market Forecast (Cardiovascular Surgery): Sales Value (in Million US$), 2024-2032
Figure 26: Global: Hemostats Market (Reconstructive Surgery): Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Hemostats Market Forecast (Reconstructive Surgery): Sales Value (in Million US$), 2024-2032
Figure 28: Global: Hemostats Market (Gynecological Surgery): Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Hemostats Market Forecast (Gynecological Surgery): Sales Value (in Million US$), 2024-2032
Figure 30: Global: Hemostats Market (Other Applications): Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Hemostats Market Forecast (Other Applications): Sales Value (in Million US$), 2024-2032
Figure 32: Global: Hemostats Market (Matrix and Gel Hemostats): Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Hemostats Market Forecast (Matrix and Gel Hemostats): Sales Value (in Million US$), 2024-2032
Figure 34: Global: Hemostats Market (Sheet and Pad Hemostats): Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Hemostats Market Forecast (Sheet and Pad Hemostats): Sales Value (in Million US$), 2024-2032
Figure 36: Global: Hemostats Market (Sponge Hemostats): Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Hemostats Market Forecast (Sponge Hemostats): Sales Value (in Million US$), 2024-2032
Figure 38: Global: Hemostats Market (Powder Hemostats): Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Hemostats Market Forecast (Powder Hemostats): Sales Value (in Million US$), 2024-2032
Figure 40: North America: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: North America: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: United States: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: United States: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Canada: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Canada: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Asia Pacific: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Asia Pacific: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: China: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: China: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Japan: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Japan: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: India: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: India: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: South Korea: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: South Korea: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Australia: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Australia: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Indonesia: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Indonesia: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Europe: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Europe: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Germany: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Germany: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: France: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: France: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: United Kingdom: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: United Kingdom: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Italy: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Italy: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Spain: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Spain: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Russia: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Russia: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Latin America: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Latin America: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Brazil: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Brazil: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Mexico: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Mexico: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Others: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Others: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Middle East and Africa: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Middle East and Africa: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Global: Hemostats Industry: SWOT Analysis
Figure 89: Global: Hemostats Industry: Value Chain Analysis
Figure 90: Global: Hemostats Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Hemostats Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Hemostats Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Hemostats Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Hemostats Market Forecast: Breakup by Formulation (in Million US$), 2024-2032
Table 5: Global: Hemostats Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Hemostats Market Structure
Table 7: Global: Hemostats Market: Key Players